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ABSTRACT 
The chitosan/β-glycerophosphate (CGP) hydrogel is a reasonably well understood thermo-
sensitive system that has been widely used as the basis for successful tissue engineering and 
drug delivery systems. The aim of this project was to characterise an optimal CGP gel 
composition for a novel ocular wound-management system. Whilst much research has been 
done into the potential applications of the CGP system over the past few decades, no literature 
is currently available on the CGP-decorin combination which was the focus of this project. 
More specifically, the potential for this system to prevent serious visual impairments by way 
of delivering corneal-healing drugs is yet to be investigated. Rheological measurements of 
various gel compositions and release profiling experiments were performed to characterise the 
effectiveness of the system. The gel was also tested for cytotoxicity and for its effectiveness 
against a range of clinically isolated multi-resistant bacteria to determine its potential for 
biomedical application. Results show that a successful thermo-sensitive CGP system, that is 
liquid at room temperature and which gels at around physiological pH, has been produced and 
is able to release both antimicrobial peptide and anti-scarring drugs. The gel has no cytotoxic 
effect on corneal fibroblast cells and is effective in limiting the colony growth of a number of 
multi-resistant bacteria. The results show that this system has positive potential for ocular 
wound-healing. 
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1 INTRODUCTION 
 
The chitosan/β-glycerophosphate (CGP) hydrogel is a reasonably well understood thermo-
sensitive system and has been widely used as the basis for successful tissue engineering 
systems. Medical application of the CGP system stems from the addition of therapeutic agents 
and polymeric additives. The effect of the addition of these agents on the thermo-gelation 
process and gel properties is not yet known and is the focus of this project. The long-term aim 
is to develop an injectable system which forms a robust gel in vitro and is able to deliver 
therapeutic agents to the wound site.  
 
1.1 Introduction to gels 
Polymer gels consist of a cross-linked network of polymer chains that are able to inflate upon 
absorption of a solvent, such as water (Derossi et al., 1991). Because of their ability to swell, 
gels have received much attention for use in drug delivery (Kwon, Han and Kim, 1991), tissue 
scaffolds (Gutowska, Jeong and Jasionowski, 2001) and other biomedical applications. Gels 
are described as a soft material, being neither completely solid nor liquid, although they do 
exhibit mechanical properties similar to those of an elastic solid. All gels contain two phases – 
the continuous phase and the solid phase, which refer to the solvent and dispersed solid 
respectively. Depending on the nature of interaction between the polymer chains, the gel can 
be described as being either chemical or physical (Larson, 1999). A chemical gel is one in 
which covalent bonds form between the polymer chains – permanent interactions which 
prevent reversibility of the gel. Chemical gel networks cannot be thermally broken and as 
such there is no transition from gel to solution (gel-sol transition) upon heating. By contrast, a 
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physical gel exhibits thermally reversible properties. Weak hydrogen bonds stabilise the 
polymer network at low temperatures and are relatively easy to break upon heating. A 
physical gel undergoes a gel-sol transition when heated (Larson, 1999).  
 
1.2 Hydrogels 
Hydrogels currently receive much attention for their potential use in novel biomedical 
applications such as tissue engineering, bio adhesives and as drug delivery systems (Hoffman, 
2002). Hydrogels are three-dimensional polymer networks containing mostly water (>90%). 
The swelling behaviour of conventional hydrogels is minimally affected by environmental 
changes; however recent developments have resulted in the production of stimuli-responsive 
hydrogels which may swell or de-swell with alterations to pH or temperature (Alarcon, 
Pennadam and Alexander, 2004). Sensitivity to environmental changes makes these hydrogels 
particularly useful, especially for biomedical applications (Park and Shalaby, 1993; Drury and 
Mooney, 2003; Masteikova, Chalupova and Sklubalova, 2005; Supper et al., 2014).  
 
1.3 Chitosan hydrogels 
Chitosan is an aminopolysaccharide derived from the partial depolymerisation and 
deacetylation of chitin, a component found in the exoskeletons of crustacean shells 
(Muzzarelli, 1977). Chitosan has proven to be advantageous for medical applications due to 
its biocompatibility (Molinaro et al., 2002) biodegradability, low cytotoxicity (Rao, 1997) and 
in recent years has received much attention as the basis of drug delivery systems (Bhattarai et 
al., 2010; Bernkop-Schurch and Dunnhaupt, 2012). In 2000, Chenite et al. developed an 
injectable, thermosensitive, pH-dependent solution based on the neutralization of chitosan by 
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Figure 1: Mechanism of deacetylation of chitin to form chitosan using NaOH. 
addition of β-glycerophosphate (GP). The resulting CGP solution is liquid at physiological pH 
and room temperature, and becomes a gel if heated to body temperature (Chenite et al., 2000). 
 
1.3.1 Production of chitosan by the deacetylation of chitin 
Chitin can be chemically deacetylated by different mechanisms (acid hydrolysis, oxidative-
reductive and nitrous acid depolymerization). The physicochemical properties and 
functionality of the resulting chitosan depend on two main factors: the degree of deacetylation 
and the degree of polymerization. In concentrated alkaline conditions acetyl groups in chitin 
are split (Figure 1) and form chitosan when the proportion of free NH2 groups in the polymer 
chain exceeds 75% (Muzzarelli, 1977). The resulting chitosan is a linear polysaccharide 
comprised of randomly distributed β-(1,4)-linked D-glucosamine and N-acetyl-D-
glucosamine units. The proportion of deacetylated D-glucosamine units relative to remaining 
N-acetyl-D-glucosamine units dictates the degree of deacetylation (DD).  
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1.3.2 Solubility of chitosan 
Chitosan is insoluble in solution above pH 6 due to the presence of positively charged, 
hydrophobic amino groups (Sogias, Khutoryanskiy and Williams, 2010). In acidic conditions, 
the conversion of NH2 groups on the chitosan to NH3
+
 allows for ionic interactions between 
the polymer chains and water molecules to form. Previous investigation into the CGP gel 
system has found chitosan to be insoluble above pH 2, as noted in the literature by use of 0.1 
M HCl solutions for dissolution prior to GP addition (Chenite et al., 2000). 
 
1.3.3 Role of glycerophosphate in CGP hydrogel formation 
The presence of cationic amine groups on chitosan enables the formulation of polyelectrolye 
complexes upon exposure to anionic molecules, such as GP. It is generally accepted that the 
mechanism for CGP gelation involves a number of interactions, including; (i) ionic cross-link 
formation between oppositely charged amine and phosphate groups on chitosan and GP 
respectively, (ii) hydrogen-bond formation due to neutralisation of chitosan by proton-
absorbing GP or (iii) hydrophobic interactions between chitosan chains (Garipey et al., 2007; 
Ganji et al., 2007; Bhattarai et al., 2010).  
 
The theory that GP is directly incorporated into the gel system was confirmed by Cho et al 
(2005) who found that the cationic charge on chitosan was decreased with the addition of GP 
and that the amount of decrease was directly proportional to GP concentration. However, 
recently GP was found to be freely diffusible out of the gel system (Filion and Buschmann, 
2013) which suggests that GP serves only as a proton acceptor for chitosan and does not 
electrostatically interact with the polymer. 
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More specifically, the recent work of Supper et al (2013) suggests that it is the polyol moiety 
of GP that is responsible for the thermal sensitivity for the gel system. High GP 
concentrations lead to faster gelation time (Ahmadi and Bruijn, 2008). It is believed that the 
glycerol moiety forms a protective shell of weak hydrogen bonds around the chitosan chain 
which shields the polymer from thermal degradation, allowing it to remain in solution at low 
temperatures. As the temperature is increased, the protective layer is disrupted and the 
chitosan chains become free to form a strong network through hydrophobic interactions. The 
higher the concentration of GP, the higher the sol/gel transition temperature (Supper et al., 
2013).  
 
1.3.4 Mechanical properties of CGP hydrogel 
Hydrogels are self-supporting networks with the ability to respond to external forces and 
which display complex rheological behaviour in the form of viscoelasticity. The storage 
modulus of a hydrogel is dependent on a number of factors, including; molecular structure 
and concentration, ionic elastic modulus, pH and temperature. The shear modulus (G*) of a 
gel, comprising storage (G’) and loss (G”) moduli describes the ratio of shear stress to shear 
strain and can be used to indicate the proportion of solid to liquid properties of the gel 
(Chenite et al., 2001; Cho et al., 2006). The storage, or elastic, modulus measures the stored 
energy of the gel, representing the elastic portion, and the loss modulus measures the energy 
that is dissipated as heat and represents the viscous portion (Meyers and Chala, 1999). A 
comparison of the relationship between elastic and viscous moduli with temperature can be 
used to characterise the sol-gel transition of CGP gel (Chenite et al., 2001). Investigation into 
the rheological properties of CGP hydrogel has identified three distinct regions of shear 
modulus behaviour as a function of temperature (Chenite et al., 2001; Cho et al., 2005; Sa-
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Lima et al., 2010) (Figure 2). Region one represents the viscoelastic fluid-like behaviour of 
the CGP solution, where both elastic and viscous moduli decrease with increasing temperature 
(Graessley, 1974). This decrease in elastic modulus can be explained by a reduction in 
molecular size, due to increased chitosan chain flexibility, and dehydration of the network 
which leads to a reduction in rheological properties (Cho et al., 2005). Region two is the 
temperature range in which both moduli suddenly increase as a result of the three-dimensional 
network formation. In this region, G’>G” due to the increase in elasticity in the system. 
Finally, region three shows a slowing of gel formation caused by an increase in viscosity of 
the newly formed network.  
 
Figure 2: The variation in G' and G" with increasing temperature (Cho et al., 2005). 
 
1.3.5 Effect of the degree of deacetylation of chitosan on gel properties 
The availability of free NH2 groups in chitosan has been found to effect the CGP gelation 
process and gel properties. Gel turbidity is determined by both DD and the homogeneity of 
the re-acetylated chitosan medium. It was found that homogenously re-acetylated chitosan 
with DD between 35 – 50% is necessary for the production of a clear gel (Berger et al., 2005). 
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Increased cross-link formation resulting from a higher DD has been found to reduce gelation 
time (Ganji et al., 2006). 88% DD produced a more uniform, porous and connective gel than 
80% DD (Chang et al., 2012) and 84% DD was able to be stored as a stable liquid at 4°C for 3 
months with no apparent change in viscosity (Ruel-Gariepy et al., 2000). 
 
1.3.6 Role of pH 
Gelation time and temperature are modulated by the pH of the CGP solution (Kim et al., 
2010). At low pH values, the free amine groups on chitosan are protonated which results in 
electrostatic repulsions between the polymer chains and solubility of the molecule. At higher 
pH values (> 6.2), the neutralisation of the chitosan chains leads to the formation of gel-like 
precipitates (Chenite et al., 2000). Upon neutralization of chitosan, electrostatic interactions 
which previously predominated between oppositely charged chitosan and GP are overcome. 
The pH sensitivity of the system is dependent on electrostatic interactions between ionic 
groups on chitosan and GP (Li et al., 2014). 
 
1.3.7 Effect of the molecular weight of chitosan on gel properties 
The appearance of the CGP hydrogel was found to become more compact and regular with 
increasing molecular weight (Zhou et al., 2008). Cho et al. (2006) suggested that higher 
molecular weight chitosan could result in gelation, even without the use of an additional 
gelling agent. It was found that drug encapsulation efficiency was highest in medium 
molecular weight chitosan-based gels (Kouchak et al., 2012) and that stronger hydrogen and 
electrostatic bonds form in formulations with higher molecular weight chitosan than in other 
formulations (Honary, Maleki and Karami, 2009). 
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1.3.8 Effect of temperature on the gelation process 
The transition of the CGP system from solution to gel is known to be temperature dependent 
(Chenite et al., 2000) and there are a number of factors contributing to this thermosensitive 
behaviour. The apparent proton dissociation constant (pKap) of chitosan is known to be highly 
temperature dependant and reduces as temperature increases (Filion, Lavertu, & Buschmann, 
2007). Proton transfer from chitosan to the GP increases with temperature which was 
confirmed by a measured reduction in pH of the gel system during the thermo-gelation 
process (Supper et al., 2013). The reduction in the ionization of chitosan, as well as increased 
thermal agitation of water molecules, contribute to a reduction in both the number of 
hydrogen bonds and cohesion of the glycerol protective shells around the chitosan molecules 
allowing gel precipitates to form (Supper et al., 2013).  
 
1.3.9 Thermoreversibility 
Ganji et al. (2006) discussed the effect of GP concentration on the thermoreversibility of the 
gel, attributing the extent of reversibility to the nature of gelation mechanism which is 
determined by the amount of GP present. At low concentrations of GP, gelation is mainly by 
the formation of temperature-dependent hydrophobic interactions which result in a thermally 
reversible gel system. However, at higher concentrations of GP (> 0.5 mol/l), hydrogen bonds 
between the chitosan and chitosan-water molecules predominate the gelation process due to 
the increased neutralising effect of GP. These interactions are independent of temperature and 
are non-reversible upon cooling.  
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1.4 Chitosan-based hydrogels for wound healing 
Chitosan hydrogels can be classified as being either chemical or physical hydrogels. Chemical 
hydrogels are formed by covalent crosslinking of chitosan with another molecule. Physical 
hydrogels are formed by reversible bonding, such as ionic interactions, secondary 
interactions, grafted chitosan hydrogels and entangled hydrogels (Berger et al., 2004). The 
application of entangled chitosan hydrogels is limited by their lack of mechanical properties 
and tendency to dissolve, whereas all other variations of chitosan hydrogels exhibit 
characteristics that make them potential stimuli-responsive drug delivery vehicles. As a 
natural polymer, chitosan is widely investigated as an antimicrobial agent for preventing and 
treating infections owing to both its intrinsic antimicrobial properties and its ability to deliver 
extrinsic antimicrobial compounds into the infection site (Dai et al., 2011). Chitosan 
hydrogels have been successfully used for drug delivery (Bhatterai, Gunn and Zhang, 2010) 
and have provided vehicles for various therapeutic agents in treatments for, tissue regrowth 
(Mattioli-Belmonte et al., 1999), burn care (Dai et al., 2011) and cancer (Wang et al., 2013). 
 
1.4.1 Bacterial infections in the eye 
As an external surface, the eye is an organ that is at continual risk of exposure to airborne 
infectious bacteria in the external environment. Bacteria invading the surface of the eye can 
lead to bacterial infections effecting the surface and/or interior of the eye. Bacterial keratitis is 
a potentially blinding infection that results in corneal ulceration and which poses a serious 
threat to vision if left untreated. Ulceration to the cornea can cause scarring which interferes 
with vision by blocking or distorting light entering the eye (WebMD, 2014). The two major 
predisposing factors to bacterial keratitis in working age population have been found to be 
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ocular trauma and contact lens wear. Contact lens wear has been found to be the main risk 
factor for developing the condition in the developed world where standards of contact lens 
hygiene in are such that the risk is greater than in a developed setting (Musa et al., 2010). A 
retrospective review of contact lens-related microbial keratitis in British Defence personnel in 
Iraq found an incidence level of 35 per 10,000 people. 17 eyes (63%) lost visual acuity (Musa 
et al., 2010).  Other influencing factors include ocular surface disease, systemic disease and 
ocular surgery (Bourcier et al., 2003). A study by Mahajan (1983) found Staphylococci, S. 
pneumoniae, and P. aeruginosa to be the main pathogens in 823 eyes with infections such as 
acute bacterial conjunctivitis, corneal ulceration and postoperative infections.  
 
1.5 Antimicrobial peptides  
Antimicrobial peptides (AMPs) are low molecular weight proteins capable of opposing 
activity of bacteria, viruses and fungi in the body. Most AMPs are both cationic and 
hydrophobic at the surface which makes them effective at interacting with microbial 
membranes that often exhibit anionic surfaces (Wimley, 2010). It is this opposition in charge 
that results in high selectivity of AMPs to microbes, due to the formation of strong 
electrostatic bonds between the molecules. Upon entry into the lipid-rich membranes, AMPs 
contribute to wound healing by killing target cells (Izadpanah and Gallo, 2005). Differences 
in the susceptibility of a single microorganism to a panel of antimicrobial peptides has been 
shown to indicate that the size, sequence, conformation, charge and overall hydrophobicity of 
the AMP are all important factors in determining its effectiveness (Brogden, 2005). Similarly, 
cell structural components specific to the strain of bacteria, such as the integrity of their cell 
walls, affects the resistance of a strain to antimicrobials. Gram-positive bacteria, those which 
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retain the colour of the crystal violet stain in the Gram stain, have a cell wall composed of a 
thick layer of peptidoglycan. By contrast, bacteria with a thin layer of peptidoglycan in their 
cell wall are classified as gram-negative and are generally found to be more resistant to 
antimicrobials due to the presence of a second outer membrane layer. 
 
1.5.1 Corneal scarring 
The cornea is a clear, dome shaped structure that is the outermost surface of the eye and 
serves to both protect the eye from external matter and focus the light that enters the eye. The 
epithelium is the cornea’s external layer that blocks foreign and harmful material from 
entering the eye; it is highly sensitive to pain and so is able to quickly detect a scratch to its 
surface. Corneal disorders can occur as a result of infection, trauma or mechanical damage 
and may result in distortion to light entering the eye. This can cause a decrease in overall 
vision, visual quality and, in the case of corneal scarring, complete sight loss (Whitcher, 
Srinivasan and Upadhyay, 2001). Where corneal infections have caused significant structural 
damage to the cornea, the most common treatment options are eye-drop administration or 
corneal transplantation.  
 
1.5.2 Decorin 
Decorin is a small leucine-rich proteoglycan found naturally occurring in the extracellular 
matrix. It is a TGF-β1/2 antagonist and is therefore able to regulate various cellular functions 
through interactions with components of the extracellular matrix (Davies et al., 2004, Hocking 
et al., 1998 and Logan et al., 1999a). There are a number of factors which make decorin 
potentially suitable to treat corneal scarring. Firstly, decorin has anti-scarring properties due 
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to its ability to decrease both TGF-β1/2 receptor activation and signalling which results in an 
interruption of the transcriptional activation of extracellular matrix production (Akhurst, 2006 
and Yamaguchi et al., 1990). Secondly, decorin is able to modify fibrogenesis of collagen and 
the resulting fibre (Reese et al., 2013) and form an activity-blocking complex with connective 
tissue growth factor (CTGF) (Vial et al., 2011). A study into corneal wound healing found 
that decorin gene therapy delivered to the stroma inhibited corneal fibrosis in vivo (Mohan et 
al., 2011).  
 
1.6 Scope of the work 
The aim of this project is to investigate the potential to combine antimicrobial peptides and 
anti-scarring drugs with an existing CGP hydrogel for use as an ocular wound healing system. 
Although much research into the CGP system has been conducted, at present no studies have 
focused on the potential for this system as an eye dressing. The project will focus on 
mechanical and medicinal properties of the gel required to ensure its success in application.  
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2  EXPERIMENTAL (MATERIALS AND METHODS) 
 
2.1 Materials 
All materials used in this project were purchased from Sigma (Poole, UK) unless stated 
otherwise. A number of molecular weight grades of chitosan were purchased from Heppe and 
are detailed in Table 1 below. 
 
Table 1: Varieties of chitosan used to create CGP hydrogel systems throughout the project. 
Material name 
Mw Grade 
(appr. kDa) 
Degree of Deacetylation (DD) 
(%) 
Chitosan 95/20 90 95 
Chitosan 95/500 350 95 
Chitosan 95/1000 400 95 
Chitosan 95/2500 500 95 
Chitosan 95/3000 600 95 
 
2.2 Sample preparation 
Following a method described by Chenite et al. (2000), a typical chitosan solution was 
obtained by dissolving chitosan (200 mg) in HCl solution (9 ml, 0.1 M) and stirring for 3 
hours using a magnetic stirrer. The resulting solution was then chilled at 4°C for 3 hours. GP 
(560 mg) dissolved in deionised water (1 ml) was added drop-wise to the chilled chitosan 
solution whilst stirring to produce a clear, homogenous liquid solution. The solution was 
incubated at 37 °C to form a gel. For certain experiments described, different concentrations 
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of antimicrobial peptide (AMP) and decorin were added to the CGP liquid solution, vortexed 
for 30 seconds and incubated at 37 °C to form a gel.  
 
2.3 Characterisation of CGP hydrogel system 
Mechanical, visual and cytotoxic properties were investigated in order to characterise both the 
structure and function of the CGP system.  
 
2.3.1 Rheological Characterisation 
The rheological characterisation of hydrogel samples was performed in an ARES rheometer 
from TA Instruments, fitted with parallel plate geometry (diameter of 35 mm). The rheometer 
used is a strain controlled instrument that consists of applying a torque and measuring the 
resultant displacement. Measurement parameters for each test are described the in the relevant 
sections below.  
 
2.3.2 Effect of molecular weight of chitosan on gel elastic modulus 
CGP gels were made as described in section 2.2. Dynamic frequency sweeps were performed 
on five different molecular weight CGP pre-gelled samples (0.2 ml, 90, 350, 400, 500, 600 
kDa). The tests were performed at room temperate and the elastic modulus (G’) was measured 
as a function of frequency under an oscillation range of 0.031 – 31Hz.  
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2.3.3 Imaging of optical properties  
Hydrogels were prepared as described in section 2.2 and applied to glass marbles that had 
been incubated at 37 °C and laid over text to demonstrate physical and optical properties of 
the system. 
 
2.3.4 Effect of temperature on gel elastic modulus 
CGP solutions were made as described in section 2.2. Temperature ramps were performed on 
CGP solutions (0.2 ml, 500 kDa) to measure the thermosensitive gelation process as indicated 
by a change in hydrogel elastic modulus. Elastic modulus (G’) was measured as a function of 
temperature under oscillation measurement of 1Hz (1 rad s
-1
).  
 
2.3.5 Cytotoxicity assay 
Cell line corneal fibroblast cells from a confluent flask were trypsinised, incubated for 5 
minutes to detach cells and blocked with media (RPMI) to inhibit trypsin action of the cell. 
Cell counts were performed and a combination of suspension (125 µl) and media (375 µl) 
wasplaced in 16 wells of a 24 well plate. Cells were then left overnight in an incubator to 
allow for attachment. CGP hydrogels (450, 500, 600 kDa) were prepared following the 
method in section 2.2 then autoclaved to form a block of each gel which were cut into 0.4 cm
3
 
units. The gels were added to the well plate and incubated for 24 hours before being removed. 
All cells were then incubated with trypsin (250 µl) and then blocked with media (250 µl). 
Cells were counted on a haemocytometer with n=6 technical repeats and n=3 biological 
repeats. 
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2.3.6 Effect of shear rate on gel viscosity 
CGP gels were made as described in section 2.2. The viscosity of CGP hydrogel (500 kDa) 
was measured by a strain-controlled steady rate sweep tests across a shear rate range of 10 – 
450 sec
-1
.  
 
2.3.7 Effect of solution on gel elastic modulus 
CGP hydrogels were made as described in section 2.2 and stored in PBS (2 ml) for one week. 
Dynamic frequency sweeps were performed at room temperate and the elastic modulus (G’) 
was measured as a function of frequency under an oscillation range of 0.031 – 31Hz to 
determine gel elastic modulus compared to a control gel. 
 
2.4 Addition of therapeutic agents to CGP gel for wound-healing 
2.4.1 Effect of AMP concentrations on gel elastic modulus 
CGP gels were made as described in section 2.2. Dynamic frequency sweeps were performed 
on pre-gelled CGP hydrogels (0.2 ml, 500 kDa) containing AMP at 0.9 % v/v, 1.9 % v/v and 
3.8 % v/v. The tests were performed at room temperate and the elastic modulus (G’) was 
measured as a function of frequency under an oscillation range of 0.031 – 31Hz.  
 
2.4.2 Release profiling of AMP 
AMP (2.9 % v/v) was added to CGP solutions (0.5ml 500 kDa) made using the method 
described in section 2.2, covered in aluminium foil and left to gel in an incubator at 37 °C. 
Upon complete gelation, any excess water was removed. PBS (2 ml) was added on top of 
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each 1 ml AMP-hydrogel sample. Plates were covered in foil and 100 µl aliquots taken at t=0, 
1, 2, 3, 4, 5, 6, 7, 24 hours. Fluorescence of plates was read at 488 nm using a Glomax multi 
detection system. 
 
2.4.3 AMP dispersion imaging 
Hydrogels were prepared as described in section 2.2. Red food dye (10 µl) was added to the 
gel and standard camera images taken to demonstrate dispersion behaviour. Separately, AMP 
(10 µl) was added to gels which were then transferred to slides and imaged at 488 nm with an 
Axioplan-2 fluorescence microscope and images obtained with AxioVision  Microscopy 
Software (both from Carl Zeiss Ltd., Hertfordshire, UK). 
 
2.4.4 Microbiology of hydrogel 
Seven strains of clinically isolated multi-resistant bacteria (Table 2) were provided as a gift by 
Dr. Beryl Oppenheim for this project.  
 
Table 2: Varieties of clinically isolated bacterial strains tested. 
Bacteria 
Methicillin Sensitive S. aureus 
Methicillin Resistant S.aureus 
Coagulase Negative Staphylococcus 
P. aeruginosa 
E. coli 
M.catarrhalis 
H. influenza 
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CGP hydrogels (50 µl, 500 kDa) were prepared with AMP (1.5% v/v) from stock solution (15 
mg/ml) and exposed to seven different strains of multi-resistant bacteria to evaluate the 
effectiveness of the antimicrobial properties of the hydrogel. LB broth was used to culture the 
bacteria on the gel during incubation at 37 °C for 24 hours.  
 
2.4.4.1 Colony forming unit (CFU) solution microbiology 
Dilution plates were prepared by adding bacteria solution from around the gel (100 µl) and 
broth (100 µl) to wells and pipetting 10 µl aliquots into consecutive wells to create a 1 in 10 
dilution along each row. From the dilution plates, solutions at each dilution (10 µl) were 
pipetted onto agar in a dropwise triangle formation. Following incubation overnight at 37°C, 
cell counts were taken by observing the number of visible units of each bacteria at a particular 
dilution factor.  
 
2.4.4.2 Hydrogel microbiology 
Hydrogel was transferred from the original into a new well plate, maintaining the same 
arrangement of wells. Alamar blue dye (10 µl) in H2O (90 µl) was added to each of the wells 
on top of the hydrogel. The plate was incubated for 1 hour and analysed at 488 nm using a 
Glomax multi detection system.  
 
2.4.5 Effect of decorin concentration on gel elastic modulus 
CGP gels were made as described in section 2.2. Dynamic frequency sweeps were performed 
on pre-gelled CGP hydrogels (0.2 ml, 500 kDa) containing decorin at 1.9 % v/v, 3.8 % v/v 
and 7.4 % v/v. The tests were performed at room temperate and the elastic modulus (G’) was 
measured as a function of frequency under an oscillation range of 0.031 – 31Hz. 
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2.4.6 Release profiling of decorin 
Decorin (5.7 % v/v) was added to CGP solutions (0.5 ml, 500 kDa) and left to gel in an 
incubator at 37 °C. Upon complete gelation, any excess water was added to the 96 well plate. 
PBS (2 ml) was added on top of each 1 ml decorin-hydrogel sample. 100 µl aliquots were 
taken at t=0, 1, 2, 3, 4, 5, 6, 7, 24 hours. Decorin ELISA kit was used to analyse according to 
manufacturer’s instructions (R&D Systems, Abingdon, UK). 
 
2.4.6.1 Decorin ELISA 
The prepared capture antibody (360 µg/ml of mouse anti-human decorin when reconstituted 
with 1 ml PBS) was selected and diluted to 60 µL/10 ml in PBS. 100 µL of the diluted capture 
antibody was used to coat each well of the 96 well plates and incubated overnight at room 
temperature. The plate was washed three times with PBS Tween-20 (0.05%) and then blocked 
by adding of reagent diluent (300 µl, 1% BSA in PBS) and incubated for at least one hour. 
Separately, standard solutions (100 ng/ml of recombinant human decorin in 0.5 ml of reagent 
diluent) were added to the 96 well dilution plate (as used in section 2.16), diluting 1000 fold 
with each new row. The blocked plate was then washed a further three times and 100 µl 
samples from the dilution plate were transferred to the ELISA plate and incubated at room 
temperature on the shaker for two hours. The wash step was repeated. 100 µl of the detection 
antibody (60 µl in 10 ml reagent diluent) was added to each well of the ELISA plate and 
incubated for two hours whilst shaking. The wash step was repeated. 100 µl of strepravidin-
HRP (60 µl in 10 ml reagent diluent) was added to each well and incubated in the dark, at 
room temperature for 20 minutes. The wash step was repeated. 100 µl of substrate solution 
was added rapidly to each well and incubated as with the strepravidin-HRP. Finally, stop 
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solution (50 µl) was added to each well and tapped gently to ensure thorough mixing. The 
plate was covered with foil and read at 488 nm using a Glomax multi detection system. 
 
2.4.6.2 NanoDrop analysis 
2 ml aliquots of PBS solution from decorin release study (section 2.4.6) of CGP gels (500 
kDa) containing decorin (7.4% v/v) vs. control gel were analysed with a NanoDrop ND-1000 
Spectrophotometer. Decorin absorbance was measured over time points 0, 0.5, 1, 2, 3, 4, 5, 6, 
7 hours at a wavelength of 220 nm. 
 
2.5 Statistical Analysis 
All statistical analysis was carried out using SPSS 17.0 (IBM SPSS Inc., Chicago, IL)and data 
was presented as mean ± SEM. The Shapiro-Wilk test was used to ensure all data was 
normally distributed before parametric testing using a one-way ANOVA with Tukey post-hoc 
test. Statistical significance threshold was p<0.05. All data was normally distributed and was 
analysed using the same method.   
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3 RESULTS 
 
3.1 Sample Preparation 
All CGP systems have shown to be a solution at room temperature and to form gels around 
physiological temperature and pH. Gelation rates across 450 kDa, 500 kDa and 600 kDa 
molecular weight gels were all in the range of 30 - 60 secs, with 90 kDa taking a longer time 
(>120 secs). The solutions changed from being a transparent liquid to an opaque solid upon 
heating. Although no differences in clarity or colour were observed in the hydrogels’ 
appearance, visual observation indicated that 90 kDa produced a more viscous gel (data not 
shown). The addition of AMP and decorin to CGP gels had no effect on the characteristics of 
the gelation process (data not shown). 
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3.2 Characterisation of CGP gel system 
3.2.1 Effect of molecular weight on gel elastic modulus 
To establish which chitosan molecular weight would produce the most robust hydrogel, 
dynamic frequency sweeps were performed on hydrogels of 4 molecular weight varieties (90 
kDa, 450 kDa, 500 kDa, 600 kDa) to measure the effect of molecular weight on elastic 
modulus (G’). The results show that there was no significant difference in G’ between the 
molecular weight grades of CGP hydrogel (Figure 3). 
 
 
 
 
 
Figure 3: Variation in G’ of hydrogels with increasing molecular weight chitosan. Mean ±SEM, n=6. Differences 
between gels are not statistically significant. 
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3.2.2 Imaging of optical properties of gel 
Application of the CGP hydrogel (500 kDa) to the surface of a glass ball at 37 °C (Figure 4) 
demonstrated the ability of the gel to form a thin (1 mm), self-supporting gel layer at 
physiological temperature. Optical clarity of the gel was shown by the ability to read text 
underneath a layer of gel (Figure 4 c).  
 
Figure 4: Images showing a), b) gelation of CGP solution upon contact with glass ‘eye’ at near body 
temperature and c) demonstration of gel clarity upon complete gelation. 
 
  
RESULTS 
24 
 
3.2.3 Effect of temperature on gel elastic modulus 
In order to identify the temperature-dependent gelation behaviour of the CGP solution, gel 
elastic modulus (G’) of CGP gel (500 kDa) was measured as a function of temperature 
between 25 – 41 °C. The resulting curve can be described in two different regions (Figure 5). 
The first region shows little change in G’ until around 33 °C where there becomes a steady 
increase in G’, indicating a possible gelation onset point. The second region is characterised 
by an abrupt increase in G’ because of the formation of the hydrogel three-dimensional 
network resulting in the sol-gel transition. The elastic modulus (G’) was greater than the loss 
modulus (G”) with increasing temperature which indicates the increase in elasticity of the 
system. Sol-gel transition temperature, characterised by a sudden increase in G’, was found to 
be near physiological temperature, at 34 °C. 
 
Figure 5 Elastic modulus of 500 kDa CGP solution as it undergoes gelation between 26 - 42°C at a rate of 
1°C/min. 
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3.2.4 Hydrogel cytotoxicity assay 
CGP hydrogels of three different molecular weights (450, 500, 600 kDa) were tested for 
toxicity in corneal fibroblast (CF) cells. The number of surviving CF cells after treatment with 
CGP hydrogels of 450 kDa, 500 kDa and 600 kDa was not significantly different from control 
(Figure 6), indicating that CGP hydrogels were not toxic to CF cells at the molecular weights 
tested.  
 
Figure 6: Number of remaining corneal fibroblast cells following application of different molecular weight CGP 
hydrogels. Means ± SEM, n=3 for control, n=5 for all hydrogel treatment conditions. 
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3.2.5 Effect of shear rate on gel viscosity 
Strain-controlled steady shear rate sweep tests were performed on CGP hydrogels (500 kDa) 
to measure the effect of shear rate on gel viscosity. A clear trend of decreasing viscosity with 
increasing shear rate between 10 – 50 Hz can be observed, after which point gel viscosity 
plateaus in the range of 0-20 Pa/s as the shear rate increases (Figure 7).  
 
 
 
 
 
 
 
Figure 7: Viscosity of hydrogel with increasing shear rate (10 – 80Hz). Means ± SEM, n=8. 
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3.2.6 Effect of solution on gel elastic modulus 
CGP hydrogels (500 kDa) stored in PBS (2 ml) for one week exhibited significantly lower gel 
elastic modulus (G’) than control (Figure 8), indicating a weakening effect of solution on the 
gel. Comparison between weight measurements of dried and hydrated CGP gels showed 
swelling to be 7 % the initial, dried weight (data not shown).  
 
 
 
 
 
 
 
 
  
0
200
400
600
800
1000
1200
1400
1600
1800
gel only (control) gel in solution
G
' 
P
a
 ±
 S
E
M
 
 
Storage condition 
Figure 8: Strength of 95/2500 grade CGP hydrogel after 1 ml gel was kept in 2 ml PBS solution for 1 week vs. 1 
ml of control CGP hydrogel. Mean ± SEM, n=3. Difference between the two conditions is deemed statistically 
significant, black line indicates P<0.05. 
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Addition of therapeutic agents  
3.2.7 Effect of AMP concentration on gel elastic modulus 
The addition of AMP will provide wound healing potential to the CGP gel system. Dynamic 
frequency sweeps were performed on CGP hydrogels (500 kDa) containing different 
concentrations of AMP to measure any effect of the addition on gel elastic modulus. In 
hydrogels containing AMP at 1.9% v/v and 3.8 % v/v, the elastic modulus was not 
significantly different from control (Figure 9). There was however a significant difference 
between hydrogel containing AMP at 3.8 % v/v and control (Figure 9), indicating that 
addition of AMP at 1.9% v/v and 3.8 % v/v has a negligible effect on gel elastic modulus, but 
at 3.8 % v/v, AMP may increase the elastic modulus of the hydrogel. 
 
Figure 9: Gel elastic modulus (G’) of 500 kDa CGP hydrogels containing different peptide concentrations. 
Mean ±SEM, n=6. Differences of release rate with different concentrations are deemed statistically significant 
(P= 0.013), black lines indicate P<0.05 
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3.2.8 Release profiling of AMP  
CGP hydrogels of three molecular weights (450, 500, 600 KDa) containing 10 µl AMP were 
tested over 48 hours to measure their effectiveness at releasing the peptide. An increase in 
AMP concentration in solution over 48 hours was recorded in all molecular weight hydrogels 
(Figure 10), indicating that AMP was successfully released from the hydrogel. The release 
followed a homogeneous profile consisting of similar increases in AMP concentration at each 
time point which resulted in a uniform curve. There was no significant difference between the 
release rates of the molecular weights. Percentage release from 450, 500 and 600 kDa CGP 
gels was 55%, 60% and 49% respectively.  
 
 
 
Figure 10: Release rate of 10 µl peptide from 0.5 ml of different molecular weight CGP hydrogels over 48 
hours. Means ± SEM, n=3. There is no significant difference between molecular weights. 
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3.2.9 Imaging of peptide dispersion through gel 
Images of the dispersion behaviour of red food dye through CGP hydrogel show a non-
homogeneous dispersion (Figure 11 a,b,c) and indicate a possible non-uniform dispersion 
behaviour of AMP in the gel. This food dye model is proved by optical microscopy images of 
CGP hydrogels (500 kDa) containing antimicrobial peptide (Figure 11 d,e,f) which show 
areas of high contrast that indicate localised concentrations of AMP within the hydrogel.  
 
 
 
  
Figure 11: a), b), c) Dispersion of red food dye through CGP hydrogel, d) Image of peptide dispersion through 
hydrogel at 5x magnification. 
1mm 
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3.2.10 Microbiology of hydrogel  
The effectiveness of CGP hydrogel (500 kDa) containing AMP was tested against seven 
different strains of multi resistant bacteria. A significant antimicrobial effect was found 
against P. aeruginosa, Methicillin Resistant S. aureus and H. influenza cells (Figure 12), with 
no significant effect found against the other strains tested. Results indicate that AMP-
containing CGP hydrogels (500 kDa) provide effective antimicrobial action against certain 
multi resistant strains of bacteria. Findings show significant differences between both 
Coagulase Negative Staphylococcus and P. aeruginosa in CFU solution compared to control 
solution. No significant difference was found between the other strains and control (Figure 
13).  
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Surviving concentrations of ten strains of multi resistant bacteria dissolved in antimicrobial 
peptide-containing CGP hydrogel (500 kDa) solutions compared to control. Means ± SEM, n=6. Black lines 
indicate p<0.05. 
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Figure 13: Remaining colony-forming units (CFU) of multi resistant bacteria in solution following exposure to 
antimicrobial CGP hydrogel. Means ± SEM, n=3. Black lines indicate p<0.05. 
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3.2.11 Effect of decorin concentration on gel elastic modulus 
With its anti-scarring properties, the addition of decorin to the CGP system provides potential 
for its use in effective wound management. Dynamic frequency sweeps were performed on 
CGP hydrogels (500 kDa) containing different concentrations of decorin to measure any 
effect of the decorin on gel elastic modulus. The elastic modulus of hydrogels containing 
decorin at 1.9 % v/v, 3.8 % v/v and 7.4 % v/v was not significantly different to control 
(Figure 14), indicating that decorin has a negligible effect on gel elastic modulus at the 
concentrations tested.  
 
 
 
 
 
 
 
  
Figure 14: Gel strength (G’) of 95/2500 grade CGP hydrogels containing different decorin concentrations. 
Mean ±SEM, n=6. Differences not deemed statistically significant (P=0.378) 
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3.2.12 NanoDrop analysis 
NanoDrop analysis showed an increase in protein absorbance over 7 hours compared to 
control and indicates a steady release of decorin over this time period (Figure 15).  
 
Figure 15: Absorbance of decorin measured with NanoDrop analysis, showing decorin released from gel over 
tim compared to control. 
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4 DISCUSSION 
 
4.1 Characterisation of CGP gel system 
4.1.1 Effect of molecular weight on gel elastic modulus 
The majority of ocular medications are administered by topical delivery methods, such as eye-
drops and ointments which take advantage of the accessibility of the eye (Kaczmarek et al., 
2014). The disadvantage of topical delivery methods is that the eye employs efficient natural 
defence mechanisms which remove foreign material and therefore mean that frequent repeat 
administration is necessary. The aim of this project was to develop an eye dressing that 
enables controlled release of drugs into the eye over a sustained period of time. Ideally, this 
novel system retains its shape at least until the required drug dosage has been released. To 
enable this to happen, the gel would be sufficiently solid upon gelation. The results indicate 
that there was no significant difference in the solidity of gels within the range of molecular 
weights tested. This result is unexpected based on previous studies which report that chitosan-
gelatine blends (Liu et al., 2011), chitosan films (Nunthanid et al., 2001) and chitosan 
adsorbing polysaccharide droplets (Hou et al., 2012) made with higher molecular weight 
chitosan all exhibit higher elastic modulus and viscosity than those made with lower 
molecular weight chitosan. Further studies have shown that chitosan complexes form stronger 
hydrogen and electrostatic bonds in formulations with higher molecular weight chitosan than 
in other formulations (Honary, Maleki and Karami, 2009). Although the degree of 
deacetylation (DD) of chitosan has been found to modulate mechanical properties of the GP 
gel (Liu et al., 2011), with higher DD giving way to greater mechanical elastic modulus, all 
chitosan grades used in this project were of ~95% DD so it is unlikely that this was an 
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influencing factor in this case. The average molecular weight tested in these studies is 290 
kDa, compared to 410 kDa in this project and so it is possible that differences in gel elastic 
modulus are less between higher molecular weight grades of chitosan. It is also possible that 
in the case of the CGP system, the addition of GP limits any increases in elastic modulus with 
molecular weight that would arise in chitosan solutions alone. The gel must be sufficiently 
rigid to hold its shape for long enough to allow the optimal dose of decorin and AMP to be 
released. Premature degradation of the gel would limit the wound-healing effectiveness of the 
system.  
 
4.1.2 Imaging of optical properties of gel 
The successful gelation of CGP on the surface of a glass sphere at 37 °C was to be expected 
based on previous reports of gelation of this system at 37 °C (Chenite et al., 2001). Further, 
the results show optical transparency of the gel which provides exciting potential for the use 
of CGP as an ocular wound dressing that still allows patient vision. The thickness of the CGP 
dressing was measured at 1 mm which is similar to that of other current eye treatments, such 
as soft and hard contact lenses whose centre thickness measures at ~ 30 µm and ~ 100 µm 
respectively. Overall the results suggest promising evidence that the CGP hydrogel could be 
used successfully on the surface of the eye without causing significant obstruction.  
 
4.1.3 Effect of temperature on gel elastic modulus 
The results show an increase in gel elastic modulus (G’) with increasing temperature, as 
expected based on previous investigation into the thermal properties of the CGP system 
(Chenite et al., 2001; Cho et al., 2005). Based on previous work, a sigmoidal curve showing 
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G’ as a function of temperature was expected and although the results do not show a high-
temperature plateau, the general shape of the curve is as expected and would likely have 
plateaued if a broader temperature had been explored. The onset of gelation, as characterised 
by an abrupt increase in G’, is shown at 34 °C which is slightly below 37 °C which has 
previously been reported as the gelation temperature of this system (Cho et al., 2005; Ahmadi 
and Bruijn, 2008). As an external surface, the cornea changes temperature depending on both 
body and ambient temperatures. Corneal temperature has been found to reach a maximum of 
37 °C, and at ambient temperature lies between 32 °C and 34.5 °C (Kessel et al., 2010). 
Therefore, in the case of corneal applications, it is advantageous for the CGP system to gel at 
34 °C or lower.  
 
4.1.4 Cytotoxicity Assay 
Corneal fibroblast (CF) cells are specialized cells found within the cornea and which play a 
major role in allowing transparency, synthesizing corneal components and effecting healing. 
Cytotoxicty measurements of the CGP gel on CF cells is important in order to determine the 
feasibility of using this hydrogel successfully for wound healing of the cornea. The 
cytotoxicity assay conducted showed that there was no significant difference in the number of 
surviving CF cells that were exposed to different molecular weight CGP gels compared to 
control. These findings are in line with previous chitosan-toxicity studies which showed low 
toxicity of chitosan in the case of intravenous, oral and nasal administration (Hirano et al., 
1989; Aspden et al., 1997; Knapczyk et al., 1989). Furthermore, Felt et al. (1999) found that 
there was good ocular tolerance for chitosan in rabbits following topical administration of a 
chitosan-based eye dressing to the corneal surface.  
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4.1.5 Effect of shear rate on viscosity 
CGP hydrogel viscosity was found to be inversely proportional to shear rate. These findings 
are supported by previous work in this area, which found the same relationship explained by 
the viscoelasticity exhibited by the system (El-hefian and Yahaya, 2010). The benefit of this 
viscoelastic behaviour is that it facilitates the movement of the eyelid during movement and 
allows the gel to retain its shape, whilst enabling surface spreading with the shearing force 
applied during blinking (Li and Chauhan, 2006). 
 
4.1.6 Effect of solution on gel elastic modulus 
After one week in solution (PBS), CGP hydrogel (500 kDa) displayed a significantly lower 
elastic modulus (G’) than control gel. Weight measurements of the hydrated CGP gel showed 
that water uptake is 7% of initial gel weight. This value is relatively low, which is to be 
expected due to the presence of GP which forms cross links with chitosan and limits the 
degree of swelling that can occur (Dusek et al., 2014).  
 
4.2 Addition of therapeutic agents 
4.2.1 Effect of peptide concentration on gel elastic modulus 
Although there was no significant difference between gels containing the polyarginine 
antimicrobial peptide at 1.9% (v/v) and 3.8 % (v/v), the significant difference (p< 0.05) 
between gel with peptide at 3.8 % (v/v) and control suggests that gel elastic modulus 
increases with peptide concentration. Previous studies showed that tensile elastic modulus of 
chitosan-PVA gels (Sung et al., 2010) and the storage and loss moduli of chitosan-collagen 
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hydrogels (Reis et al., 2012) were unaffected by the addition of proteins. However, Rask et 
al., (2010) found that elongation was significantly greater in chitosan formulations containing 
peptide than those without. As discussed in section 1.4.2, the polyarginine antimicrobial 
peptide used in this study is highly positively charged and therefore provides an abundance of 
sites for the electrostatically charged CGP network to bind to. In section 1.3.5 the effect of 
NH2 groups on chitosan on CGP network formation was discussed and it was reported that a 
greater number (resulting from a higher DD) produced a more uniform and connected gel. It 
is possible therefore that the addition of polyarginine AMP, as a positively charged molecule, 
results in the formation of strong ionic bonds between chains which increases the integrity of 
the system.  
 
4.2.2 Peptide release rate with molecular weight 
As expected, peptide was successfully released from all CGP gels, however the rate of release 
was not significantly different between the molecular weights of chitosan tested which is 
contrasting to previous findings in this area (Desai, Liu and Park, 2006). In previous studies, 
chitosan hydrogels containing high molecular weight chitosan exhibit lower release rates than 
other molecular weights (Honory, Maleki and Karami, 2009). Khodaverdi et al. (2012) found 
that increasing both GP and peptide concentrations resulted in slower release rates. These 
findings indicate that the rate of peptide release involves a number of parameters and that in 
this project the effect of chitosan molecular weight may have been modulated by the 
concentrations of GP and peptide used. A release profile of insulin from CGP gels showed a 
biphasic response, with an initial low burst followed by steady release over the following days 
(Khodaverdi et al., 2012). Similarly, the results of this project show an increasing short-term 
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peptide release (0-7 hours) which indicates a steady peptide release immediately following 
application that would be advantageous to the wound healing properties of the eye dressing.  
 
4.2.3 Imaging of peptide dispersion through gel 
Results of peptide addition to the CGP gel show a non-homogeneous dispersion.  
 
4.2.4 Microbiology of hydrogel 
Results of antimicrobial testing on the CGP gel show that it has a significant effect against H. 
influenza, Methicillin Resistant S. aureus and Coagulase Negative Staphylococcus cells and 
CFU solution tests showed significant differences between Coagulase Negative 
Staphylococcus and compared to control. In the case of bacteria being less present on the 
surface of the antimicrobial gel than on control (Fig. 12), it is likely that the peptide has 
worked effectively in killing target bacterial cells. Results of CFU solution may have a 
number of explanations and will depend on the release of peptide out of the cell and 
movement of bacteria into the gel. For example, a low bacterial count in solution could mean 
either the peptide has migrated into solution and successfully targeted the bacteria, or that the 
bacteria have migrated into the gel and out of solution.  
 
4.2.5 Effect of decorin concentration on gel elastic modulus 
The results show that decorin concentration did not have a significant effect on gel elastic 
modulus. Although currently there has been little investigation into the addition of decorin to 
hydrogels, previous decorin studies suggest that its functionality is modulated by an ability to 
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self-associate (Bittner et al., 1996). This self-association may lead to low interaction with the 
CGP network, causing decorin to have a negligible effect on gel properties and rather act in a 
similar way to the solvent. Alternatively, by comparison to the increase in gel elastic modulus 
with peptide concentration, it is likely to be the charge density of each molecule which 
dictates the extent of its effect on the CGP network and as a molecule with low charge 
density, that decorin is unable to form strong bonds with the existing network structure. A 
combination of low charge density and self-assembly properties may be the reason for decorin 
having no effect on gel elastic modulus.   
 
4.2.6 Release profile of decorin  
Investigation was carried out by way of NanoDrop analysis on the release medium to measure 
short-term decorin absorbance. Results of this test, which measures all protein present in the 
sample, showed an increase in absorbance over 7 hours compared to control and indicates a 
steady release of decorin over this time period. As discussed by Li and Chauhan (2006), a 
longer residence time of the ophthalmic drug is beneficial for ensuring full drug delivery. 
Ideally, the CGP system would provide sufficient robustness to enable decorin to be fully 
released at a rate that it can be absorbed readily by the target tissue. To further increase the 
efficiency of the system and speed up the wound-healing process, decorin would be released 
steadily over a short time period, for example a couple of hours. This would decrease the 
treatment time and enable the patient to return to full health quickly.    
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5 CONCLUSIONS 
A successful thermosensitive CGP gel system that is liquid at room temperature and which 
gels at 34 °C has been produced. Furthermore, antimicrobial and anti-scarring agents have 
been successfully incorporated into the system, at no expense of the mechanical properties of 
the gel and which are able to be released steadily from the gel into solution. Therapeutic 
properties and low cytotoxicity of the gel have been proved and provide promising evidence 
for the use of this system in a wound-healing application.  
 
6 FURTHER WORK 
6.1 Cytotoxicity studies 
To develop the CGP gel for use in ocular wound healing, further cytotoxicity studies should 
be  done to investigate possible toxic effects on a wider range of ocular cells. In application, 
the gel would interact with both endothelial cells and keratocytes on the cornea.  Investigating 
possible cytotoxic effects on the latter cells would be particularly important due to their role 
in general repair and maintenance of the cornea. The studies should follow a similar process 
to the study described in this report.  
 
6.2 Mechanical testing 
Further mechanical tests should be carried out to investigate the effect of repeated stresses, 
caused by eye movement, on the performance and structure of the gel. Tensile testing would 
be useful to determine the tensile strain of the gel and understand its ability to return to its 
original shape following an applied tensile load, such as that of the eyelid. Perhaps most 
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useful would be to determine the tensile elastic modulus of the gel, as indicated by the tensile 
stress applied at the point of yielding. Tensile stress should be used to give the elastic 
modulus of the gel which indicates its hardness. Similarly, to be able to predict the movement 
of the gel in application, it would be necessary to model the movement of solution across the 
surface of the eye and measure the release rate of therapeutic agents from the gel in this 
dynamic environment.  
 
6.3 Microbiology studies 
Further testing should be conducted on a wider range of bacteria to develop understanding of 
the clinical potential for the gel. As well as bacteria related to corneal disease, bacteria 
commonly associated with other body conditions should be tested for toxicity to determine 
the effectiveness of the gel in other areas.  
 
6.4 In vivo drug release study 
Following satisfactory laboratory studies, the CGP-decorin system should be tested in vivo. In 
compliance with relevant standards in animal testing, the gel should be injected onto the 
surface of the mouse cornea following corneal damage (i.e. a cut).  The robustness of the gel 
should be observed both with and without eyelid interference to determine the longevity of 
the system.  
To determine the release profile of decorin in vivo, and also the effectiveness of the system at 
corneal-healing, the gel should be injected into a number of mice. At set time points, for 
example every hour, the gel would be removed from one of the mice and the extent of healing 
observed/measured by the amount of healthy tissue that has been regenerated.
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